Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms
Authors:
- Michele M. CastroMCMichele M. Castro
- Elen RizziERElen Rizzi
- Ricardo R. RascadoRRRicardo R. Rascado
- Jose E. Tanus-SantosJTJose E. Tanus-Santos
- 1 September 2004
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 498 (1-3) , 189-194
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Acute Vasodilator Effects of HMG-CoA Reductase Inhibitors: Involvement of P13-kinase/Akt Pathway and Kv ChannelsJournal of Cardiovascular Pharmacology, 2003
- Statin effects beyond lipid lowering—are they clinically relevant?European Heart Journal, 2003
- Sildenafil citrate does not affect cardiac contractility in human or dog heartCurrent Medical Research and Opinion, 2003
- Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic ratsInternational Journal of Cardiology, 2001
- Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular diseaseCardiovascular Research, 2001
- Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the ratBritish Journal of Pharmacology, 2000
- Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic MiceStroke, 2000
- Use of sildenafil (Viagra) in patients with cardiovascular diseaseJACC, 1999
- Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1995
- Regulation of the mevalonate pathwayNature, 1990